Gene · 6196
Papers2,567
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,567
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MAPK signaling links BRD2 chromatin occupancy to PI3K/AKT inhibitor sensitivity. | bioRxiv | 2026 | 42818240 | PubTator, text mining | PubMed |
| A multi-omics Mendelian randomization study identifies putatively causal genes and pathways for Alzheimer's disease associated with reactive astrocytes. | J Alzheimers Dis | 2026 | 42775789 | PubTator, text mining | PubMed |
| Dual Targeting of FGFR4 and PI3K-mTOR Suppresses Tumor-Associated Phenotypes in Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2026 | 42737619 | PubTator, text mining | PubMed |
| PDK1 signaling in cancer: Current status and future perspectives. | Int J Biol Macromol | 2026 | 42716156 | PubTator, text mining | PubMed |
| Investigation of psychosocial stress and DNA methylation in genes related to immune response, metabolism, and calcium signaling among African American and White middle-aged adults. | Environ Epigenet | 2026 | 42698993 | PubTator, text mining | PubMed |
| Genomic insights into stroke recovery: cross-phenotype associations. | Brain Commun | 2026 | 42695012 | PubTator, text mining | PubMed |
| Placental Epigenetic Alterations and IL-10 Dysregulation Drive Early Persistent Food Allergy. | Allergy | 2026 | 42618975 | PubTator, text mining | PubMed |
| Construction and validation of a nomogram for the diagnosis of postmenopausal osteoporosis. | Mol Med Rep | 2026 | 42596822 | PubTator, text mining | PubMed |
| Integrating dynamic modeling of signaling pathways with subject-specific transcriptomic data to assess breast cancer risk. | PLoS One | 2026 | 42594127 | PubTator, text mining | PubMed |
| EPHA2/CD44-directed trafficking enhances endosomal leakiness and antisense therapy delivery. | J Cell Biol | 2026 | 42578958 | PubTator, text mining | PubMed |
| RSK signaling in myeloid malignancies: biology, disease dependency, and therapeutic targeting. | Front Cell Dev Biol | 2026 | 42499707 | PubTator, text mining | PubMed |
| FGFR1 induces RSK-dependent non-canonical activation of EphA2 during EMT. | Biochim Biophys Acta Mol Cell Res | 2026 | 42480940 | PubTator, text mining | PubMed |
| LSD1-GLS2 axis drives subtype-specific chemoresistance in pancreatic cancer through glutaminolysis reprogramming. | Cell Death Dis | 2026 | 42476970 | PubTator, text mining | PubMed |
| Discoidin domain receptor 1 contributes to colorectal cancer progression by promoting cell migration and invasion. | Life Sci | 2026 | 42462480 | PubTator, text mining | PubMed |
| Selective targeting of RSK signaling with PMD-026 suppresses FLT3-activated acute myeloid leukemia while sparing normal hematopoiesis. | Leukemia | 2026 | 42380665 | PubTator, text mining | PubMed |
| Proteomic and phosphoproteomic profiles of time-dependent dynamic changes in LPS-induced macrophage polarization. | J Proteomics | 2026 | 42336198 | PubTator, text mining | PubMed |
| Phosphosite-specific co-regulation networks of MELK kinase: insights from integrative global phosphoproteomes. | J Genet Eng Biotechnol | 2026 | 42309608 | PubTator, text mining | PubMed |
| Combined MEK1/2 and Autophagy Inhibition Suppresses Tumor Growth via STING-Mediated Type I Interferon Response in iCCA. | Cancer Sci | 2026 | 42227200 | PubTator, text mining | PubMed |
| Decoding the Raf-Mek-Erk-Rsk pathway in prostate cancer: from molecular mechanisms to clinical opportunities. | Br J Cancer | 2026 | 42129337 | PubTator, text mining | PubMed |
| The E3 ligase β-TRCP1 earmarks OTUD3 for destruction to fine-tune cGAS activation. | J Biol Chem | 2026 | 41999888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6196/papers